AARON SHUPP: Open Payments
NPI 1194164806 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,537 in 93 payments from 22 companies in 2025. Trend: 2023 $1,350 · 2024 $1,462 · 2025 $1,537
Food & beverage: $1,537
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $272 |
| AstraZeneca Pharmaceuticals LP | 5 | $172 |
| Amgen Inc. | 22 | $156 |
| Lilly USA, LLC | 10 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $78 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| PFIZER INC. | 3 | $65 |
| Novo Nordisk Inc | 4 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $60 |
Products named: VRAYLAR, JARDIANCE, BREZTRI, Kerendia, OTEZLA, MOUNJARO, XIFAXAN, AREXVY.
Industry payments across CO — which companies pay providers there.
